<code id='8C58A1A219'></code><style id='8C58A1A219'></style>

<acronym id='8C58A1A219'></acronym>

<center id='8C58A1A219'><center id='8C58A1A219'><tfoot id='8C58A1A219'></tfoot></center><abbr id='8C58A1A219'><dir id='8C58A1A219'><tfoot id='8C58A1A219'></tfoot><noframes id='8C58A1A219'>

<optgroup id='8C58A1A219'><strike id='8C58A1A219'><sup id='8C58A1A219'></sup></strike><code id='8C58A1A219'></code></optgroup>

<b id='8C58A1A219'><label id='8C58A1A219'><select id='8C58A1A219'><dt id='8C58A1A219'><span id='8C58A1A219'></span></dt></select></label></b><u id='8C58A1A219'></u>

~~<i id='8C58A1A219'><strike id='8C58A1A219'><tt id='8C58A1A219'><pre id='8C58A1A219'></pre></tt></strike></i>~~

Home» explore» comprehensive

comprehensive

comprehensive

author：comprehensive 2025-10-06 13:32:51 Page View：743

close-up of psoriasis on a hand. -- biotech coverage from STAT — A close-up of psoriasis on a hand. Adobe

San Francisco startup Alumis Inc. has raised $259 million in a bid to best big pharma’s work in plaque psoriasis.

Alumis announced its Series C round Wednesday and plans to move its lead drug into Phase 3 trials. Venture firm Foresite Capital, which incubated Alumis, co-led the financing with Samsara BioCapital and venBio Partners.

advertisement

Alumis’ lead drug, ESK-001, is an oral medicine designed to help patients with the most common type of psoriasis by inhibiting a signaling protein called TYK2. Research has shown that the TYK2 protein plays a role in diseases where the immune system overreacts, which has made it a popular drug target in recent years.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Are infertility treatments 'essential' during the Covid
Next article： Heart attack and stroke risk calculators need revising

explore

Hollywood unions extend contract negotiations for actors

Hollywood unions extend contract negotiations for actors

1:36HollywoodwritersandtheirsupportersfromtheSAGAFTRAactors'unionwalkthepicketlineoutsideWarnerBrosS

The EU Joint Clinical Assessment needs to live up to its promise

The EU Joint Clinical Assessment needs to live up to its promise

RonaldWittek,PoolPhotoviaAPToday,thecriteriausedtoassesstheclinicalvalueofnewpharmaceuticalsandmedic

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

WASHINGTON--TheSupremeCourtwillreviewarulingstrikingdownadomesticviolencefederalgunban.

After a decade, new Gardasil ad campaign gets it (mostly) right

Screengrabviaversedhpv.comWhileclickingthroughSnapchattheotherday,anadforMerck’snewVersedcampaignfor

read more